Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease
Crossref DOI link: https://doi.org/10.1007/s40121-016-0130-1
Published Online: 2016-09-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Figueras-Aloy, Josep
Manzoni, Paolo
Paes, Bosco
Simões, Eric A. F.
Bont, Louis
Checchia, Paul A.
Fauroux, Brigitte
Carbonell-Estrany, Xavier
Funding for this research was provided by:
AbbVie